Olmesartan Medoxomil

Diabetic Nephropathies, Hypertensive disease, multiple antihypertensive drugs likely required + 1 more

Treatment

2 FDA approvals

20 Active Studies for Olmesartan Medoxomil

What is Olmesartan Medoxomil

Olmesartan

The Generic name of this drug

Treatment Summary

Olmesartan is a type of drug called an angiotensin II receptor blocker (ARB). It works by blocking the action of a protein called angiotensin II which helps regulate blood pressure. Olmesartan is used to treat hypertension and can also help slow the progression of kidney damage caused by diabetes. It is usually taken orally as olmesartan medoxomil, a prodrug which is converted to the active form, olmesartan, in the body. Olmesartan was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.

Benicar

is the brand name

image of different drug pills on a surface

Olmesartan Medoxomil Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Benicar

Olmesartan

2002

340

Approved as Treatment by the FDA

Olmesartan, also called Benicar, is approved by the FDA for 2 uses which include Therapeutic procedure and Hypertensive disease .

Therapeutic procedure

Used to treat failed primary treatment in combination with Hydrochlorothiazide

Hypertensive disease

Used to treat High Blood Pressure (Hypertension) in combination with Hydrochlorothiazide

Effectiveness

How Olmesartan Medoxomil Affects Patients

Olmesartan works by lowering blood pressure, decreasing aldosterone levels, and helping the body get rid of salt. It may cause low blood pressure in those who are dehydrated or taking high doses of diuretics. People with aortic stenosis may be at risk of decreased blood flow to their heart. Olmesartan may also cause changes in kidney function and electrolyte imbalances. Long-term use may lead to severe, chronic diarrhea with weight loss, and it can cause villous atrophy in the intestines. Monitor electrolyte levels regularly while taking olmesartan.

How Olmesartan Medoxomil works in the body

Olmesartan belongs to a group of drugs called angiotensin receptor blockers (ARBs). These drugs block a protein called angiotensin II from binding to the angiotensin receptor 1 (AT1) in your blood vessels. This helps reduce blood pressure, lower aldosterone levels, reduce heart activity, and help your kidneys excrete more sodium. Olmesartan also works on the renin-angiotensin-aldosterone system (RAAS). This system helps control kidney, vascular, and cardiac functions. By blocking the RAAS, it can help protect the heart from malfunctioning and improve

When to interrupt dosage

The proposed dosage of Olmesartan Medoxomil relies upon the diagnosed circumstance, including Diabetic Nephropathy, Hypertensive malady and Therapeutic procedure. The measure of dosage fluctuates as per the technique of delivery (e.g. Oral or Tablet, film coated) specified in the table underneath.

Condition

Dosage

Administration

Diabetic Nephropathies

40.0 mg, , 20.0 mg, 5.0 mg, 10.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated - Oral, Tablet, coated

Hypertensive disease

40.0 mg, , 20.0 mg, 5.0 mg, 10.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated - Oral, Tablet, coated

multiple antihypertensive drugs likely required

40.0 mg, , 20.0 mg, 5.0 mg, 10.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated - Oral, Tablet, coated

Therapeutic procedure

40.0 mg, , 20.0 mg, 5.0 mg, 10.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated - Oral, Tablet, coated

Warnings

Olmesartan Medoxomil has a single contraindication and should not be ingested if you are afflicted with any of the conditions presented in the table below.

Olmesartan Medoxomil Contraindications

Condition

Risk Level

Notes

Type 2 Diabetes

Do Not Combine

There are 20 known major drug interactions with Olmesartan Medoxomil.

Common Olmesartan Medoxomil Drug Interactions

Drug Name

Risk Level

Description

Amifostine

Major

Olmesartan may increase the hypotensive activities of Amifostine.

Lithium carbonate

Major

The serum concentration of Lithium carbonate can be increased when it is combined with Olmesartan.

Lithium citrate

Major

The serum concentration of Lithium citrate can be increased when it is combined with Olmesartan.

Lithium hydroxide

Major

The serum concentration of Lithium hydroxide can be increased when it is combined with Olmesartan.

Acebutolol

Minor

Olmesartan may increase the hypotensive activities of Acebutolol.

Olmesartan Medoxomil Toxicity & Overdose Risk

Tests have shown that the toxic dose of olmesartan in dogs is greater than 1500 mg/kg. Symptoms of an overdose may include low blood pressure, fast heart rate, and slow heart rate when the parasympathetic nervous system is stimulated. If someone overdoses on olmesartan, supportive care is recommended. Tests have not found any cancer-causing or fertility-related effects from taking olmesartan, however laboratory tests have shown that it may cause chromosomal abnormalities or mutations in cells.

image of a doctor in a lab doing drug, clinical research

Olmesartan Medoxomil Novel Uses: Which Conditions Have a Clinical Trial Featuring Olmesartan Medoxomil?

19 active trials are currently in progress to investigate the potential of Olmesartan Medoxomil in providing Therapeutic relief, managing Hypertension and determining when multiple antihypertensive agents are likely necessary.

Condition

Clinical Trials

Trial Phases

Hypertensive disease

27 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Diabetic Nephropathies

0 Actively Recruiting

Therapeutic procedure

0 Actively Recruiting

multiple antihypertensive drugs likely required

0 Actively Recruiting

Olmesartan Medoxomil Reviews: What are patients saying about Olmesartan Medoxomil?

5

Patient Review

4/19/2016

Olmesartan Medoxomil for High Blood Pressure

I had tried numerous prescription drugs to control my high blood pressure brought on by my fibromyalgia and diabetes. This is the ONLY drug that has worked for me, period. No side effects. Downside - very expensive.

5

Patient Review

8/27/2016

Olmesartan Medoxomil for Diastolic Heart Failure

I didn't have any issues with this treatment.

5

Patient Review

4/19/2016

Olmesartan Medoxomil for High Blood Pressure

This treatment was the only one that worked for me to control my high blood pressure. It's very expensive, but it doesn't have any side effects. The downside is that it's very expensive and my insurance wouldn't cover the dosage my doctor prescribed, so we had to come up with a plan that would be acceptable to Medicare. So far, so good.

5

Patient Review

8/27/2016

Olmesartan Medoxomil for Diastolic Heart Failure

I had no issues with this treatment.

4.7

Patient Review

3/26/2018

Olmesartan Medoxomil for High Blood Pressure

The only downside to this medication is that, since I've been taking it, mosquitos love me. Other than that, it's great!

4.7

Patient Review

11/15/2016

Olmesartan Medoxomil for High Blood Pressure

I've been taking this for two years now with great results. My blood pressure was 145/90 and is now 128/80. I haven't experienced any negative side effects that I know of.

4.7

Patient Review

11/15/2016

Olmesartan Medoxomil for High Blood Pressure

I've been taking benicar for a few years now and it's really helped to lower my blood pressure. I'm 51 years old, and have had no negative side effects that I know of.

4.7

Patient Review

3/26/2018

Olmesartan Medoxomil for High Blood Pressure

The only downside to this medication is that, since I've been taking it, mosquitos are really drawn to me. It's quite frustrating because I get bitten way more than anyone else does.

4

Patient Review

3/19/2019

Olmesartan Medoxomil for High Blood Pressure

I've been on Benicar Hctz for a long time, and it suddenly started making me feel dizzy. My doctor took me off of it and just put me on regular Benicar. I'm starting tomorrow and hoping for the best.

4

Patient Review

3/19/2019

Olmesartan Medoxomil for High Blood Pressure

I've been taking Benicar for over a decade and it's helped me immensely. Recently, I started getting dizzy so my doctor took me off of the medication. I'm starting back on it tomorrow sans Hctz to see how that goes.

3.7

Patient Review

1/3/2019

Olmesartan Medoxomil for High Blood Pressure

I'm experiencing a lot of negative side effects from this drug that are really impacting my quality of life. I'm hoping to be able to change or discontinue the medication soon.

3.7

Patient Review

1/3/2019

Olmesartan Medoxomil for High Blood Pressure

I'm hoping to get off this drug because it's causing me a lot of problems like acid reflux, stomach swelling, pain in my joints and tendons, fatigue, and weight gain. The only plus is that it controls my blood pressure.

3.3

Patient Review

11/20/2015

Olmesartan Medoxomil for High Blood Pressure

While Benicar does help to control my blood pressure better than other medications, it has caused me a great deal of dehydration and higher creatinine levels. I also sweat profusely from even small amounts of work, which is extremely inconvenient.

3.3

Patient Review

5/12/2016

Olmesartan Medoxomil for High Blood Pressure

I had heartburn within moments of taking this medication, and it also really messed with my bowel movements. The worst part, by far, was the constant heartburn. I stopped taking it as a result.

3.3

Patient Review

11/20/2015

Olmesartan Medoxomil for High Blood Pressure

Even though Benicar has controlled my blood pressure better than some other medications I've tried, I have had many problems with dehydration and higher than normal creatinine levels. I have terrible head sweating when doing even small amounts of work. Doing any work at all results in sopping wet hair.

3.3

Patient Review

5/12/2016

Olmesartan Medoxomil for High Blood Pressure

I got heartburn as soon as I took this medication, and it also really messed up my bowel movements. The constant heartburn was the worst part, so I stopped taking it.

2.3

Patient Review

12/21/2015

Olmesartan Medoxomil for High Blood Pressure

I found that there were too many negative side effects to justify taking this medication long-term. It did help keep my blood pressure down, but not enough to make up for everything else.

2.3

Patient Review

12/21/2015

Olmesartan Medoxomil for High Blood Pressure

I saw too many negative long-term changes as a result of taking this medication. It did help to lower my blood pressure, but not without some serious trade-offs that I wasn't willing to make.

2.3

Patient Review

8/28/2016

Olmesartan Medoxomil for High Blood Pressure

I cannot recommend this drug, as it has the potential to be deadly. I don't understand why it's still on the market, given that there are over 1200 pending lawsuits against the company.

2.3

Patient Review

8/28/2016

Olmesartan Medoxomil for High Blood Pressure

I would not recommend this drug to anyone. There are a lot of pending lawsuits against the company for deaths allegedly caused by this medication, which is inexcusable.

2

Patient Review

11/22/2015

Olmesartan Medoxomil for High Blood Pressure

Terrible side effects. I experienced severe migraines and the worst back pain I've ever felt between my shoulders. My whole body felt like it was being crushed. Do not take this medicine.

2

Patient Review

11/22/2015

Olmesartan Medoxomil for High Blood Pressure

Really not worth it. The migraines and back pain were unbearable, plus all the other cold symptoms. And on top of that, it makes your urine smell weird. So tired all the time too.

1.7

Patient Review

8/8/2018

Olmesartan Medoxomil for High Blood Pressure

I found that this drug caused me to lose some of my memories. I would forget numbers that I had known for years, and I had to start looking them up in the phone book. Once I stopped taking the medication, my memory came back.

1.7

Patient Review

2/17/2016

Olmesartan Medoxomil for High Blood Pressure

I didn't have a good experience with this medication. I felt incredibly tense and edgy, like all my muscles had been overworked. It also wasn't very effective at controlling my blood pressure.

1.7

Patient Review

2/17/2016

Olmesartan Medoxomil for High Blood Pressure

I found this medication to be incredibly ineffective and, frankly, dangerous. My blood pressure readings were all over the place while I was on it, and I felt awful – like my muscles had been worked to exhaustion. If you're considering this treatment, I would urge you to look elsewhere.

1.7

Patient Review

8/8/2018

Olmesartan Medoxomil for High Blood Pressure

I experienced memory loss while taking this drug. I went from being able to recite telephone numbers that I had known for years to having to look them up in the directory. Once I stopped taking the drug, my memory came back.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about olmesartan medoxomil

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the difference between olmesartan and olmesartan medoxomil?

"The discontinuation of olmesartan has resulted in an improvement of symptoms in all patients that were taking the medication for sprue-like enteropathy. Olmesartan medoxomil is a drug that is approved to treat high blood pressure, either by itself or with other medications. It is one of eight similar drugs that are currently on the market."

Answered by AI

How long does it take for olmesartan medoxomil to work?

"They usually start working within 1-2 hours and their effects usually last all day with one dose."

Answered by AI

What are the side effects of olmesartan medoxomil?

"If you are feeling dizzy or tired, have a headache, flu-like symptoms, a runny or stuffy nose, a cough, or bronchitis, you may have COVID-19. You may also have pain in your back, bones, or joints; feel sick (nausea) or have indigestion; have a stomach ache; or diarrhoea. Other symptoms include swollen feet, ankles, legs, or hands (oedema), or a urinary tract infection (UTI)."

Answered by AI

What is olmesartan medoxomil used for?

"Olmesartan is used by itself or with other medications to manage high blood pressure (hypertension). High blood pressure puts added strain on the heart and arteries. If it continues for a long time, it can damage the heart and arteries so they don't function properly."

Answered by AI

Clinical Trials for Olmesartan Medoxomil

Image of Miles Square Health Center Chicago in Chicago, United States.

Food is Medicine for High Blood Pressure and Obesity

Any Age
All Sexes
Chicago, IL

The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?

Phase 2
Waitlist Available

Miles Square Health Center Chicago (+3 Sites)

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.

Waitlist Available
Has No Placebo

U Health (+1 Sites)

Ziad Zoghby, M.D., M.B.A.

Biobeat Technologies Ltd.

Have you considered Olmesartan Medoxomil clinical trials?

We made a collection of clinical trials featuring Olmesartan Medoxomil, we think they might fit your search criteria.
Go to Trials
Image of Wayne Health Mobile Units in Detroit, United States.

Text Message Reminders for High Blood Pressure

18+
All Sexes
Detroit, MI

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).

Recruiting
Has No Placebo

Wayne Health Mobile Units

Steven J Korzeniewski, PhD

Have you considered Olmesartan Medoxomil clinical trials?

We made a collection of clinical trials featuring Olmesartan Medoxomil, we think they might fit your search criteria.
Go to Trials
Image of Northern Arizona University in Flagstaff, United States.

CardioCare Quest for High Blood Pressure

18+
All Sexes
Flagstaff, AZ

This project aims to address healthcare disparities among Navaho people diagnosed with hypertension or prehypertension through three main objectives. Firstly, it identifies and shares insights on healthcare access disparities affecting Navaho individuals experiencing nonadherence to hypertension treatment. Secondly, the proposal develops a telehealth solution based on factors identified as knowledge gaps caused by healthcare access disparities in hypertension management; we will use the factors to design a series of engaging minigames that can be incorporated into the larger CardioCare Quest. These minigames will be co-designed with end users and clinicians. Finally, the proposal conducts comprehensive qualitative and quantitative assessments of user experiences, perceptions, and challenges with CardioCare Quest.

Recruiting
Has No Placebo

Northern Arizona University (+1 Sites)

Tochukwu Ikwunne, PhD

Image of Tufts University in Boston, United States.

Food as Medicine for Cardiometabolic Health

18+
All Sexes
Boston, MA

Though the Mississippi Delta has a rich agricultural history and some of the nation's most fertile soil, residents have experienced the legacy of slavery and economic exploitation through food insecurity and poverty for generations. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta Growing a Resilient, Enriching, Equitable, Nourishing food System (GREENS) Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Recruiting
Has No Placebo

Tufts University

Christina D Economos, PhD

Have you considered Olmesartan Medoxomil clinical trials?

We made a collection of clinical trials featuring Olmesartan Medoxomil, we think they might fit your search criteria.
Go to Trials